The role of NUB1 in α-synuclein degradation in Lewy body disease model mice

Biochemical and Biophysical Research Communications
Kunikazu TanjiKoichi Wakabayashi

Abstract

Abnormal α-synuclein is deposited in neuronal cytoplasmic inclusions and presynapses in Parkinson's disease (PD) and dementia with Lewy bodies (DLB). Previously we have shown that NUB1 is accumulated in these specific regions together with abnormal α-synuclein and that NUB1 is able to inhibit α-synuclein aggregation in cultured cells. We therefore created transgenic (Tg) mice expressing both NUB1 and abnormal α-synuclein to investigate the role of NUB1 on degradation of abnormal α-synuclein in vivo. Immunohistochemical and biochemical studies confirmed that NUB1 was over-expressed in neurons of mice expressing NUB1 (NUB1 Tg), and both NUB1 and abnormal α-synuclein (double Tg). NUB1 levels were increased by 4.7-fold in NUB1 Tg mice compared with wild type mice. Unexpectedly, normal and abnormal α-synuclein levels were unchanged between abnormal α-synuclein Tg mice (Lewy body disease model mice) and double Tg mice, and pathological observations were almost similar between them. Finally, we found that the levels of insoluble α-synuclein were lower and those of some chaperone molecules were higher in double Tg mice compared with abnormal α-synuclein Tg mice. These results suggest that increased levels of NUB1 play a potential role ...Continue Reading

References

Aug 28, 1997·Nature·M G SpillantiniM Goedert
Nov 14, 1997·The Journal of Biological Chemistry·T KamitaniE T Yeh
Oct 21, 1999·Journal of Medical Genetics·Y NarainD C Rubinsztein
Mar 22, 2001·The Journal of Biological Chemistry·K KitoT Kamitani
Oct 5, 2001·The Journal of Biological Chemistry·T KamitaniE T Yeh
Jun 21, 2003·The Journal of Biological Chemistry·Tomoaki TanakaTetsu Kamitani
Feb 6, 2004·The Journal of Biological Chemistry·Mark Steffen HippGunter Schmidtke
Mar 11, 2004·European Journal of Biochemistry·Tomoaki TanakaTetsu Kamitani
Jan 7, 2005·Neuropathology and Applied Neurobiology·F MoriK Wakabayashi
Sep 21, 2005·Biochemical and Biophysical Research Communications·Kunikazu TanjiTetsu Kamitani
Aug 1, 2006·The American Journal of Pathology·Kunikazu TanjiTetsu Kamitani
Feb 9, 2007·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Michael L Kramer, Walter J Schulz-Schaeffer
Feb 29, 2008·Neuroscience Letters·Hai-Xin ZhangKoichi Wakabayashi
Sep 23, 2011·Journal of Neuropathology and Experimental Neurology·Kunikazu TanjiKoichi Wakabayashi
May 28, 2015·Methods : a Companion to Methods in Enzymology·Frederik LermyteFrank Sobott

❮ Previous
Next ❯

Citations

Jun 18, 2016·Journal of Huntington's Disease·Petr VodickaMarian DiFiglia

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bioinformatics in Biomedicine

Bioinformatics in biomedicine incorporates computer science, biology, chemistry, medicine, mathematics and statistics. Discover the latest research on bioinformatics in biomedicine here.

Alpha-Synuclein Aggregation (MDS)

Alpha-synucleins are small proteins that are believed to restrict the mobility of synpatic vesicles and inhibit neurotransmitter release. Aggregation of these proteins have been linked to several types of neurodegenerative diseases including dementia with Lewy bodies and Parkinson's disease. Here is the latest research on α-synuclein aggregation.

Alpha-Synuclein Aggregation

Alpha-synucleins are small proteins that are believed to restrict the mobility of synpatic vesicles and inhibit neurotransmitter release. Aggregation of these proteins have been linked to several types of neurodegenerative diseases including dementia with Lewy bodies and Parkinson's disease. Here is the latest research on α-synuclein aggregation.